Bliss GVS Pharma Ltd.
BSE: 506197 | Sector: Health care |
NSE: BLISSGVS | ISIN Code: INE416D01022 |
BSE 00:00 | 26 Feb | 174.60 |
0.10 (0.06%) |
OPEN
175.70 |
HIGH
176.00 |
LOW
173.20 |
NSE 00:00 | 26 Feb | 174.60 |
0.20 (0.11%) |
OPEN
175.00 |
HIGH
176.55 |
LOW
173.00 |
OPEN | 175.70 |
PREVIOUS CLOSE | 174.50 |
VOLUME | 241932 |
52-Week high | 224.00 |
52-Week low | 82.50 |
P/E | 24.08 |
Mkt Cap.(Rs cr) | 1,800 |
Buy Price | 174.60 |
Buy Qty | 1.00 |
Sell Price | 174.60 |
Sell Qty | 199.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bliss GVS Pharma Ltd. (BLISSGVS) - Financial Overview
Particulars (![]() |
2020 | 2019 | 2018 |
Net Sales | 441.95 | 426.59 | 297.89 |
Operating Profit | 135.10 | 128.91 | 99.45 |
Other Income | 34.93 | 35.81 | 11.00 |
Interest | 4.56 | 3.15 | 6.95 |
Depreciation | 8.83 | 5.75 | 5.67 |
Profit Before Tax | 121.71 | 120.01 | 86.83 |
Tax | 29.38 | 45.58 | 29.82 |
Profit After Tax | 92.33 | 74.43 | 57.01 |
Share Capital | 10.31 | 10.31 | 10.31 |
Reserves | 672.63 | 592.96 | 531.11 |
Net Worth | 682.94 | 603.27 | 541.42 |
Loans | 95.52 | 73.44 | 95.75 |
Gross Block | 203.03 | 94.14 | 84.25 |
Investments | 18.31 | 18.31 | 18.31 |
Cash | 86.62 | 93.29 | 70.29 |
Debtors | 404.91 | 342.09 | 282.54 |
Net Working Capital | 580.59 | 536.48 | 545.04 |
Operating Profit Margin (%) | 30.57 | 30.22 | 33.38 |
Net Profit Margin (%) | 20.89 | 17.45 | 19.14 |
Earning Per Share (Rs) | 8.95 | 7.22 | 5.53 |
Dividend (%) | 50.00 | 100.00 | 100.00 |
Dividend Payout | 12.41 | 12.41 | 6.19 |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices